GSK

39.045 -0.14 (-0.37%)

GSK plc Sponsored ADR · NYSE

Performance

+2.86%

1W

+8.18%

1M

+12.05%

3M

-9.54%

6M

+16.66%

YTD

-5.44%

1Y

Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Technical Analysis of GSK 2025-03-11

The stock exhibits a strong bullish sentiment with a Moving Average Score of 91, indicating robust upward momentum, while the Oscillators Score of 37 suggests some bearish pressure that could temper enthusiasm. Overall, the Technical Score of 64 reinforces a generally positive outlook, though caution may be warranted due to the weaker oscillator...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Stock Analysis of GSK

Created with Highcharts 11.1.060605858848467670100
QualityGrowthMomentumValue4

Stock Rank

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.